Optimizing biologic therapy in the adjuvant setting: HER2-targeting agents and antiangiogenesis
转载请注明来自丁香园
Sandra M. Swain,Director, Washington Cancer Institute,Washington Hospital Center
Professor of Medicine,Georgetown University,Washington DC
作者: 丁香园通讯员
以下网友留言只代表网友个人观点,不代表网站观点 | |||
Copyright 2000-2025 DXY.CN All Rights Reserved